PBPHPortfolio Building Block World Pharma and Biotech Index ETF
Tracks the performance of the BITA Global Pharma and Biotech Select Index.
By Portfolio Building Block ETFs · Launched 2025
Annual Cost
0.13%
#505 of 5,854 · low cost
Fund Size
$859M
#1,219 of 5,854 · large
Return (1Y)Goal
N/A
Track Record
9 months
#4,918 of 5,854 · young
Performance
Total-return NAV · USDGrowth of $10,000
$10,854+8.5%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
GlobalCap
Multi cap
Strategy
Index tracking
Sector
Health careFocus
Biotech & Genomics
Index tracked
BITA Global Pharma and Biotech Select Index
What it actually holds
By weightConcentration
Top 10 holdings = 62.4% of fundconcentrated
Eli Lilly and CoLLY
15.9%
Johnson & JohnsonJNJ
9.6%
AbbVie IncABBV
7.0%
Merck & Co IncMRK
5.0%
Novartis AG Registered SharesNOVN.SW
4.5%
Roche Holding AG Ordinary Shares newROP.SW
4.5%
Amgen IncAMGN
4.4%
AstraZeneca PLCAZN.L
4.3%
Gilead Sciences IncGILD
3.7%
Novo Nordisk AS Class BNOVO-B.CO
3.6%
Asset allocation
Stocks
99.7%
Cash
0.3%
By sector
Healthcare
100.0%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-11.1%Mild
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- NASDAQ Global Select Market
Full fund details
- Objective
- Tracks the performance of the BITA Global Pharma and Biotech Select Index.
- Strategy
- Uses a passive management approach to track the BITA Global Pharma and Biotech Select Index, investing primarily in ordinary shares of companies in the pharmaceutical and biotechnology sectors with a market capitalization of at least $10 billion. The Fund invests at least 80% of its net assets in component securities of the Index, which includes companies listed on major stock exchanges in developed markets.
- Inception date
- November 25, 2025
- Fund family
- Portfolio Building Block ETFs
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at PBPH. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03